AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 66 min read$HCAT

Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5%

Health Catalyst (NASDAQ:HCAT) reported Q2 CY2026 revenue of $70.49 million, down 12.7% year on year, but above analysts’ estimates by 2.1%. Non-GAAP EPS was $0.04, in line with consensus. Next-quarter revenue guidance was $55.5 million, 10.7% below estimates. The stock fell 25.5% to $1.71 after results.

Original reporting
financialcontent.com
Published Aug 6, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5% — source image
Source · financialcontent.com
Decision brief

The 30-second read

$HCATBearishMed
01

Why it matters

Traders should focus on the forward revenue guidance miss and the company’s cash-related billings trend and customer acquisition efficiency, which can affect liquidity and demand expectations.

02

Market read

Despite a Q2 revenue beat, the weaker next-quarter revenue guidance and negative cash/efficiency signals align with the reported 25.5% stock drop.

03

What to watch

The article highlights billings and CAC payback deterioration, but it does not quantify contract duration, churn, or backlog quality, which could change the interpretation of the revenue guide.

Relevance 7/10Novelty 6/10Timing: post-market reaction, same-day selloff after Q2 results

Background

Health Catalyst is a healthcare data analytics provider using its “Health Catalyst Flywheel” approach, and this article frames its Q2 CY2026 results versus expectations.

Company-level read

Ticker impact

$HCATBearishMedium confidence
Context

Health Catalyst beat Q2 revenue expectations but guided next-quarter revenue to $55.5M, 10.7% below estimates, and shares fell 25.5%.

Expected impact

Bearish near-term bias, with follow-through risk if investors focus on the revenue guide and billings/CAC deterioration rather than the Q2 beat.

Evidence & confidence

The article provides concrete datapoints: Q2 revenue $70.49M (beat by 2.1%), next-quarter revenue guidance $55.5M (10.7% below estimates), and a 25.5% immediate stock drop, plus billings and CAC payback deterioration that can reinforce liquidity and demand concerns.

Market effects

Sector

Reinforces that healthcare analytics/software names can trade on forward revenue guidance and cash-related metrics, not just quarterly beats.

Regional

Limited, single-name earnings reaction with no broader macro/regional catalyst cited.

Global

Low, no international deal/regulatory developments mentioned.

Counterpoint

What could challenge this read

The company exceeded the high end of revenue guidance and matched non-GAAP EPS, so the selloff may over-discount a single-quarter guide if execution improves in subsequent quarters.

Key entities

  • company
    Health Catalyst

    NASDAQ-listed healthcare data analytics company reporting Q2 CY2026 results and next-quarter revenue guidance.

  • executive
    Ben Albert

    CEO quoted saying the company exceeded the high end of revenue guidance and the midpoint of adjusted EBITDA guidance.

Read at source← All news

Related articles

AUG 7
$HCATHighAI 9/10

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst (NASDAQ: HCAT) shares fell 23.1% after the company issued a weak Q3 revenue forecast and cut its full-year outlook. It expects Q3 revenue of $55.5 million versus $70.49 million in Q2, and reduced 2026 revenue guidance to $247.5 million at the midpoint. Q2 revenue met expectations, but the outlook pressured the stock.

financialcontent.com4 min
AUG 6
$HCATMedAI 8/10

M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix

Health Catalyst, Inc. said it closed the July 31, 2026 sale of Vitalware, LLC to Med-Metrix, LLC. The divestiture generated $147M in total cash consideration, subject to adjustments. Health Catalyst plans to use proceeds and cash on hand to fully repay its credit facility, removing about $19M in annual GAAP interest expense, and to focus on its core healthcare intelligence and AI platform.

hitconsultant.net4 min
AUG 6
$HCATHigh

Health Catalyst, Inc. (HCAT): Results of Operations and Financial Condition

Health Catalyst, Inc. (HCAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2ex991-earningspress.htm EX-99.1 Document Exhibit 99.1 Health Catalyst Reports Second Quarter 2026 Results SALT LAKE CITY, UT, August 6, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measur

SEC EDGAR 8-K6 min
AUG 8
$LEEMed

Lee Enterprises, Incorporated Q3 2026 Earnings Call Summary

Lee Enterprises reported Q3 2026 progress toward a digital-first model, saying digital revenue was 57% of total revenue. It cited a 15% cash cost reduction and fifth straight quarter of comparable adjusted EBITDA growth, raising full-year adjusted EBITDA guidance to 22% to 28%. The company expects about $18M annual interest savings, positive net income of $5.2M, and plans debt paydown using excess cash and non-core asset sales.

yahoo.com6 min
AUG 8
$LNGMed

Cheniere Energy, Inc. Q2 2026 Earnings Call Summary

Cheniere Energy’s Q2 2026 call cited production outperformance and faster Corpus Christi Stage 3 startup for a second guidance raise. Full-year 2026 adjusted EBITDA guidance was revised to $7.9B-$8.4B. Management expects Sabine Pass Phase 1 FID by early 2027, targets dividend growth of at least 10% annually, and issued $1.75B dual-tranche bonds extending maturities to 2056.

yahoo.com6 min
AUG 8
$MARAMed

Marathon Digital Holdings, Inc. Q2 2026 Earnings Call Summary

Marathon Digital Holdings (MARA) discussed its Q2 2026 shift from Bitcoin mining to power-centric AI infrastructure. Management said it aims to expand energized power capacity to 4.8 GW via Matagorda and the pending Long Ridge deal, projected to add about $144 million annualized EBITDA. MARA reported a $611 million net loss, including a $343 million unrealized fair value adjustment tied to a 28% lower Bitcoin average price.

yahoo.com6 min